Dr. Pulsipher received a doctoral degree in chemistry at the University of North Carolina at Chapel Hill and completed a Howard Hughes Medical Institute postdoctoral fellowship in chemical glycobiology at the California Institute of Technology. Prior to joining the U, she directed the research and preclinical development of new therapeutic solutions at GlycoMira Therapeutics, aimed at improving the care, quality of life, and outcomes for patients with chronic rhinosinusitis, while also evaluating the feasibility of synthetic glycosaminoglycans as cancer supportive care agents in mitigating radiation-induced oral mucositis. During this time, she formed a strong collaborative research partnership with the Rhinology Team and aided in basic sciences investigations focused on elucidating underlying molecular mechanisms in chronic rhinosinusitis, as well as translational studies to develop minimally invasive methods to diagnose specific endotypes of chronic rhinosinusitis.
RESEARCH INTEREST
The UROC Innovations Lab seeks to address critical gaps in the understanding, evaluation, and management of inflammatory diseases using basic science and translational approaches with new strategies to identify novel biomarkers for optimized diagnostics and personalized clinical care.
RELATED LINKS
Education History
| Postdoctoral Fellowship |
University of Utah School of Medicine |
Postdoctoral Fellowship |
|---|---|---|
|
California Institute of Technology/Howard Hughes Medical Institute |
Postdoctoral Fellowship | |
| Doctoral Training |
University of North Carolina at Chapel Hill |
PhD |
|
University of Virginia |
BS | |
| Undergraduate |
James Madison University |
Anthropology |
Selected Publications
Journal Article
-
Mahomva CR, Smith KA, Minkah PAB, Witt BL, Oakley GM, Orlandi RR, Alt JA, Pulsipher A. Chemokine CCL19 and Its Receptors CCR7 and CCRL1 in Chronic Rhinosinusitis. J Inflamm Res. 2024; 2024(17):2991-3002.
PMID: 38764495 DOI: 10.2147/JIR.S453567 -
Massey CJ, Oakley GM, Orlandi RR, Ashby S, Alt JA, Smith KA, Pulsipher A. An eosinophil peroxidase activity assay predicts acute exacerbations in post-operative chronic rhinosinusitis. Int Forum Allergy Rhinol. 2024; online ahead of print. PMID: 38767584 DOI: 10.1002/alr.23366
-
Shipman PA, Yathavan B, Gill AS, Pollard CE, Yellepeddi V, Ghandehari H, Alt JA, Pulsipher A, Smith KA. Quantification of budesonide retained in the sinonasal cavity after high-volume saline irrigation in post-operative chronic rhinosinusitis. Am J Rhinol Allergy. 2024; 38(3):169-177. PMID: 38456692 DOI: 10.1177/19458924241237839